2022
Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders
Gibson B, Hoff E, Haas A, Adams ZM, Price CR, Goddard-Eckrich D, Sheth SS, Dasgupta A, Meyer JP. Overlapping needs for sexual and reproductive health and HIV prevention in women with substance use disorders. Women's Health 2022, 18: 17455065211070543. PMID: 35023410, PMCID: PMC8771433, DOI: 10.1177/17455065211070543.Peer-Reviewed Original ResearchConceptsSubstance use disordersPre-exposure prophylaxisUse disordersHIV preventionReproductive healthReproductive health service utilizationHigh HIV risk behaviorHealth service utilizationUnique health issuesCross-sectional evaluationHIV risk behaviorsHigh unmet needReproductive health behaviorsReproductive health needsConcurrent clinical trialsForm of contraceptionTime of assessmentPregnancy intentionReproductive ageClinical trialsUnintended pregnancyService utilizationCriminal justice involvementDrug treatmentContraceptive use
2015
Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV
Sheth SS, Coleman J, Cannon T, Milio L, Keller J, Anderson J, Argani C. Association between depression and nonadherence to antiretroviral therapy in pregnant women with perinatally acquired HIV. AIDS Care 2015, 27: 350-354. PMID: 25616659, DOI: 10.1080/09540121.2014.998610.Peer-Reviewed Original ResearchConceptsHistory of depressionHIV RNA levelsAntiretroviral therapyThird trimesterMedication adherencePregnant womenMean HIV RNA levelUndetectable HIV RNA levelsCharts of womenHIV infection characteristicsLifelong chronic illnessRNA levelsRetrospective cohort studyPoor medication adherenceUnique psychosocial challengesOptimal medication adherenceTreatment of depressionUnstable living situationsPregnant patientsCohort studyPreconception periodPregnancy outcomesART nonadherenceHIV treatmentPrenatal care